Cardiawave Announces First Routine Treatments Performed with Valvosoft® Following CE Mark Approval and Accelerates Its DeploymentAfter ...

People who underwent a minimally invasive procedure to have their heart's aortic valve replaced had similar health outcomes years after treatment as people who had surgery, Cedars-Sinai investigators ...

Patients with a dysfunctional aortic heart valve who received a new, prosthetic valve through a minimally invasive procedure had similar outcomes at five years as those who underwent open-heart ...

Cardiawave today announced the first patients treated in routine clinical practice in Europe with its Valvosoft platform.

A prospective, non-inferiority, randomised controlled TCW trial at 18 tertiary centres (2018-2023). Patients (n = 172) had severe aortic stenosis and complex coronary artery disease. They were ...

Within days of a transcatheter aortic valve replacement procedure at Independence Health Westmoreland Hospital, Bob Weaver ...

Transcatheter aortic valve replacement (TAVR) demonstrated better short-term outcomes, while surgical aortic valve replacement (SAVR) had better long-term outcomes. A recent study found that when it ...

EAST PROVIDENCE, R.I. (WPRI) — It’s a serious heart defect that can cause blood to flow into the wrong part of the heart chamber, and up until recently, it required open heart surgery to fix. But now ...

Background Congenital aortic stenosis (ConAoS) accounts for approximately 4%–8% of all congenital heart diseases. Chronic ...

With a market cap of $50.5 billion, Edwards Lifesciences Corporation (EW) is a leading medical technology company ...